<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02547532</url>
  </required_header>
  <id_info>
    <org_study_id>Fsalvatoremaugeri</org_study_id>
    <nct_id>NCT02547532</nct_id>
  </id_info>
  <brief_title>Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency</brief_title>
  <acronym>AATD</acronym>
  <official_title>Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Salvatore Maugeri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Spedali Civili di Brescia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Grifols Biologicals Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione Salvatore Maugeri</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the context of the increasing evidence of the pathogenetic role of microbiome in COPD, our
      aim is to determine the total and specific bacterial and viral load in sputa from patients
      with COPD due to AATD and to correlate these findings with cellular, biochemical and
      immunological characteristics of sputa. These quantitative data obtained from sputum will be
      analyzed in the context of the clinical and physiological parameters of the patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>composition of microbioma in sputa</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation with clinical and physiological parameters</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Alpha-1 Antitrypsin Deficiency</condition>
  <arm_group>
    <arm_group_label>usual COPD</arm_group_label>
    <description>Patients meeting the diagnostic criteria for COPD and without AATD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal smokers</arm_group_label>
    <description>subjects with a history of smoking, without symptoms, without AATD and with normal lung function</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal non smokers</arm_group_label>
    <description>subjects without a history of smoking, without symptoms, without AATD and with normal lung function</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AATD not treated</arm_group_label>
    <description>patients with COPD, with AATD and not on augmentation therapy for AATD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AATD treated</arm_group_label>
    <description>patients with COPD, with AATD on augmentation therapy for AATD</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of sputum</intervention_name>
    <arm_group_label>usual COPD</arm_group_label>
    <arm_group_label>normal smokers</arm_group_label>
    <arm_group_label>normal non smokers</arm_group_label>
    <arm_group_label>AATD not treated</arm_group_label>
    <arm_group_label>AATD treated</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Normal volunterrs Patients with COPD without AATD Patients with COPD and with AATD
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of COPD and a clinical stable condition, i.e. at least three months from the
             last AECOPD and/or antibiotic treatment.

        For patients with AATD this condition will be diagnosed by laboratory tests showing low
        levels of AAT and genotyping of AATD-related genes.

        . Exclusion Criteria:

          -  The presence of important co-morbidities (diabetes, systemic or organ infections,
             immunodeficiency, tumors, moderate-severe heart failure) will be considered as
             exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pantaleo Giannuzzi, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Fondazione Salvatore Maugeri</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruno Balbi, M.D., Ph.D.</last_name>
    <phone>+39-0322-884711</phone>
    <phone_ext>4982</phone_ext>
    <email>bruno.balbi@fsm.it</email>
  </overall_contact>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2015</study_first_submitted>
  <study_first_submitted_qc>September 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2015</study_first_posted>
  <last_update_submitted>September 9, 2015</last_update_submitted>
  <last_update_submitted_qc>September 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Salvatore Maugeri</investigator_affiliation>
    <investigator_full_name>Bruno Balbi</investigator_full_name>
    <investigator_title>Head, Pulmonary Rehabilitation Department</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>alpha-1 antitrypsin deficiency</keyword>
  <keyword>microbioma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alpha 1-Antitrypsin</mesh_term>
    <mesh_term>Protein C Inhibitor</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

